Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2009 2
2010 4
2011 3
2012 1
2013 2
2015 1
2019 1
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Benralizumab for the Prevention of COPD Exacerbations.
Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators. Criner GJ, et al. N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112385 Clinical Trial.
Pharmacological treatment of COPD.
Menezes AM, Macedo SE, Noal RB, Fiterman J, Cukier A, Chatkin JM, Fernandes FL; Grupo de Trabalho, Sociedade Brasileira de Pneumologia e Tisiologia; Grupo de Trabalho do Programa de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas. Menezes AM, et al. Among authors: fiterman j. J Bras Pneumol. 2011 Jul-Aug;37(4):527-43. doi: 10.1590/s1806-37132011000400016. J Bras Pneumol. 2011. PMID: 21881744 Free article. Review. English, Portuguese.
2021 Brazilian Thoracic Association recommendations for the management of severe asthma.
Carvalho-Pinto RM, Cançado JED, Pizzichini MMM, Fiterman J, Rubin AS, Cerci Neto A, Cruz ÁA, Fernandes ALG, Araujo AMS, Blanco DC, Cordeiro Junior G, Caetano LSB, Rabahi MF, Menezes MB, Oliveira MA, Lima MA, Pitrez PM. Carvalho-Pinto RM, et al. Among authors: fiterman j. J Bras Pneumol. 2021 Dec 15;47(6):e20210273. doi: 10.36416/1806-3756/e20210273. eCollection 2021. J Bras Pneumol. 2021. PMID: 34932721 Free PMC article. Review.
Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma.
Wechsler ME, Laviolette M, Rubin AS, Fiterman J, Lapa e Silva JR, Shah PL, Fiss E, Olivenstein R, Thomson NC, Niven RM, Pavord ID, Simoff M, Hales JB, McEvoy C, Slebos DJ, Holmes M, Phillips MJ, Erzurum SC, Hanania NA, Sumino K, Kraft M, Cox G, Sterman DH, Hogarth K, Kline JN, Mansur AH, Louie BE, Leeds WM, Barbers RG, Austin JH, Shargill NS, Quiring J, Armstrong B, Castro M; Asthma Intervention Research 2 Trial Study Group. Wechsler ME, et al. Among authors: fiterman j. J Allergy Clin Immunol. 2013 Dec;132(6):1295-302. doi: 10.1016/j.jaci.2013.08.009. Epub 2013 Aug 30. J Allergy Clin Immunol. 2013. PMID: 23998657 Free PMC article. Clinical Trial.
Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial.
Wunderink RG, Laterre PF, Francois B, Perrotin D, Artigas A, Vidal LO, Lobo SM, Juan JS, Hwang SC, Dugernier T, LaRosa S, Wittebole X, Dhainaut JF, Doig C, Mendelson MH, Zwingelstein C, Su G, Opal S; CAPTIVATE Trial Group. Wunderink RG, et al. Am J Respir Crit Care Med. 2011 Jun 1;183(11):1561-8. doi: 10.1164/rccm.201007-1167OC. Epub 2011 Feb 4. Am J Respir Crit Care Med. 2011. PMID: 21297074 Clinical Trial.
A workshop on asthma management programs and centers in Brazil: reviewing and explaining concepts.
Stelmach R, Cerci Neto A, Fonseca AC, Ponte EV, Alves G, Araujo-Costa IN, Lasmar LM, Castro LK, Lenz ML, Silva P, Cukier A, Alves AM, Lima-Matos AS, Cardoso Ada R, Fernandes AL, São-José BP, Riedi CA, Schor D, Peixoto DM, Brandenburg DD, Camillo EG, Serpa FS, Brandão HV, Lima JA, Pio JE, Fiterman J, Anderson Mde F, Cardoso Mdo S, Rodrigues MT, Pereira MN, Antila M, Martins SM, Guimarães VG, Mello YA, Andrade WC, Salibe-Filho W, Caldeira ZM, Cruz-Filho ÁA, Camargos P. Stelmach R, et al. Among authors: fiterman j. J Bras Pneumol. 2015 Jan-Feb;41(1):3-15. doi: 10.1590/S1806-37132015000100002. J Bras Pneumol. 2015. PMID: 25750669 Free PMC article.
Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma.
Cukier A, Jacob CM, Rosario Filho NA, Fiterman J, Vianna EO, Hetzel JL, Neis MA, Fiss E, Castro FF, Fernandes AL, Stirbulov R, Pizzichini E; AIR Brazilian Study Group. Cukier A, et al. Among authors: fiterman j. Respir Med. 2013 Sep;107(9):1330-8. doi: 10.1016/j.rmed.2013.06.018. Epub 2013 Jul 9. Respir Med. 2013. PMID: 23849625 Free article. Clinical Trial.
18 results